Cakici, C. Et Al. 2024. LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. JOURNAL OF CANCER , vol.15, no.3 , 590-602.

Cakici, C., Daylan, B., Unluer, R. S., Emekli-Alturfan, E. I., Ayla, S., Gozel, H. E., ... Yigit, P.(2024). LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer. JOURNAL OF CANCER , vol.15, no.3, 590-602.

Cakici, Cagri Et Al. "LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer," JOURNAL OF CANCER , vol.15, no.3, 590-602, 2024

Cakici, Cagri Et Al. "LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer." JOURNAL OF CANCER , vol.15, no.3, pp.590-602, 2024

Cakici, C. Et Al. (2024) . "LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer." JOURNAL OF CANCER , vol.15, no.3, pp.590-602.

@article{article, author={Cagri Cakici Et Al. }, title={LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer}, journal={JOURNAL OF CANCER}, year=2024, pages={590-602} }